Researchers at Stanford and the Chan Zuckerberg Biohub have developed a transcriptomic characterization of human endometrium and identified specific gene signatures for use in evaluating endometrial samples for one or more menstrual cycle events.
Proliferative vitreoretinopathy (PVR) is a rare ocular condition that can lead to vision loss or blindness and is a complication of rhegmatogenous retinal detachment, severe diabetic retinopathy, and other conditions.
Physicians at Stanford Lucile Packard Children's Hospital (LPCH) have developed a novel Vesico-Amniotic Shunt (VAS) for treatment of Prenatal Lower Urinary Tract Obstruction (LUTO).
Researchers at Stanford are developing a device that uses quantum engineered states and interactions to detect electromagnetic waves with a sensitivity and bandwidth beyond that possible with existing technology.
Researchers at Stanford University have developed a clinical transrectal imaging system for detection of prostate cancer using dual ultrasound and real-time photoacoustic imaging.
Cancer specific antigenic epitopes called neoantigens are necessary for effective adoptive T cell therapies. Neoantigens generate cytotoxic T lymphocytes (CTLs) and CTLs can be exploited to safely target and eliminate cancerous cells.
Stanford researchers have developed a method to use conditional generative adversarial networks (C-GANs) for solving highly complex optimization problems, e.g., with 1050 to 10 80 dimensions.
Low doses of agents that activate BMP signaling (such as FK506) could be used to prevent the progression of bladder cancer and potentially treat breast, colon and other types of epithelial-derived cancer. This technology is based on the discovery by Prof.
Stanford researchers at the Poon Lab have developed a method for battery-less, short range transmission of data with very low power and very high data rates. It can potentially replace current near field communications (NFC) systems due to these advantages.
Researchers at Stanford University have developed a method to induce antigen-specific immunological tolerance to allow for more effective gene replacement therapy for Duchenne muscular dystrophy (DMD).
Stanford researchers in the Vuckovic group have developed an optical phased array (OPA) for solid-state beam-steering in optical systems such as LIDAR, projectors, and microscopy.